Clinical trials: COVID19 Testing
Covid19 Virus Infection
Building Resiliency and Vital Equity (BRAVE) Project: Understanding Native Americans' Perceptions/Beliefs About COVID-19 Testing and Vaccination Study
The Building Resilience and Vital Equity (BRAVE) project seeks to partner with American Indian tribal communities in North Carolina to establish COVID-19 services and resources for American Indian communities.
- Trial name
- BRAVE (NCT04964154)
- Testing
- Protect Your Elders Campaign
- Where
- United States
- Volunteers
- 4,000 people, healthy volunteers welcome
- Sponsor
- North Carolina Central University
COVID-19
Genosvid Diagnostic Test for Early Detection of COVID-19
Electronic-nose had been used to diagnose other infectious lung diseases, such as tuberculosis. Universitas Gadjah Mada has developed an electronic-nose device which is easy-to-use, portable, and can be manufactured at a low…
- Trial name
- NCT04558372
- Testing
- exhaled breath sampling
- Where
- 8 sites in Indonesia
- Volunteers
- 1,999 people
- Sponsor
- Gadjah Mada University
COVID-19
The Measurement of Chemicals in Exhaled Breath Can Identify If a Person is Infected with COVID-19
The type and number of chemicals in exhaled breath are different in people with infection as compared to those without infection. In this study, the breath of people with and without COVID infection will be measured.
- Trial name
- NCT06571136
- Where
- United States
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- N5 Sensors
Covid19
Long-term Follow-up Findings of Inpatients for COVID-19 Pneumonia
Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus (SARS-CoV-2) that can progress to severe multiorgan disease requiring hospitalization.
- Trial name
- NCT04599998
- Testing
- spirometry, thoracic CT, CPET, 6 minute walking test, SF-36 questionnaire
- Where
- Turkey (Türkiye)
- Volunteers
- 28 people
- Sponsor
- Koc University Hospital
COVID-19
Health Information Technology for COVID-19 Testing in Schools (SCALE-UP Counts)
This project will address key testing challenges in Utah schools by building on collaborations with public school districts, private schools, charter schools and with Utah Department of Health on coronavirus disease (COVID-19)…
- Trial name
- NCT05112900
- Testing
- Text Messaging (TM), Text Messaging + Health Navigation (TM+HN)
- Where
- United States
- Volunteers
- 7,122 people, healthy volunteers welcome
- Sponsor
- University of Utah
Influenza A, Influenza Type B
FINDER® Instrument and FINDER® FLU A/B, RSV, SARS-CoV-2 Test Clinical Evaluation Protocol
The goal of this observational study is to compare the FINDER FLU A/B, RSV, SARS-CoV-2 Test to an FDA-cleared device. The study will utilize prospectively collected de-identified nasopharyngeal samples obtained from both…
- Conditions
- Influenza A, Influenza Type B, SARS CoV 2 Infection, RSV Infection
- Trial name
- NCT05928507
- Testing
- Diagnostic Test for identification of influenzas A, influenzas B, RSV and SARS-CoV-2 infections
- Where
- United States
- Volunteers
- 2,500 people
- Sponsor
- Baebies, Inc.
Olfaction Disorders, COVID-19 Testing
Rapid Screening for Olfactory Disorders in Covid-19 Infection
Loss of smell is very frequently found in Europe during Covid-19 attack. This symptom was not initially expected as part of the classic symptomatology.
- Trial name
- OLFASCAN (NCT04696601)
- Testing
- Olfactory test
- Where
- France
- Volunteers
- healthy volunteers welcome
- Sponsor
- Centre Hospitalier Universitaire de Nice
COVID-19
Rapid Acceleration for Diagnostics in Underserved Populations: Home Testing
This observational, cohort sub-studyis embedded within a larger public health intervention that distributes at-home, self-administered, SARS-CoV-2 antigen testing kits to households within pre-selected communitiesthrough the…
- Trial name
- SYCT (NCT04949243)
- Testing
- Behavioral questionaires
- Where
- 2 sites in United States
- Volunteers
- 338 people, healthy volunteers welcome
- Sponsor
- Duke University
COVID - 19
You and Me Healthy: Test to Treat
The COVID-19 pandemic dramatically increased health disparities. In the United States, >79 million have been infected with SARS-CoV-2 and >900,000 died, but cases and deaths disproportionately affect underserved populations.
- Trial name
- YMTT (NCT07126392)
- Where
- 2 sites in United States
- Volunteers
- 913 people, healthy volunteers welcome
- Sponsor
- Duke University
SARS-CoV 2
IgG/IgM Antibody Test in Patients Who Have Tested Negative or Positive for COVID-19 With the Standard Method of COVID19 Testing.
The purpose of this study is to evaluate point of care SARS-Cov2 Virus IgG/IgM rapid test cassette Clungene test and correlate it with the standard method of testing in inpatients who have tested positive or negative for COVID19.
- Trial name
- NCT04402814
- Testing
- Clungene rapid test cassette
- Where
- 3 sites in United States
- Volunteers
- 90 people
- Sponsor
- Fadi Haddad, M.D.
Dysosmia, Anosmia
Treatment of Pediatric Patients That Lost Sense of Smell Due to COVID-19
This research study is a randomized controlled trial in pediatric and young adult patients who have lost their sense of smell due to COVID-19 viral infection. The goals are: 1.
- Conditions
- Dysosmia, Anosmia, Covid19
- Trial name
- NCT04964414
- Testing
- Smell Retraining, Budesonide
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- Amanda Stapleton
COVID-19 Vaccines
Strategies for Combining the First Component of Sputnik V With Other Adenoviral or mRNA-based Vaccines.
To determine whether a heterologous vaccination regimen in individuals with no known previous history of COVID-19 is non-inferior to that observed with counterpart regimens currently in use in Argentina among persons aged 21 to…
- Trial name
- NCT05027672
- Testing
- Gam-COVID-Vac (rAd26) / Gam-COVID-Vac (rAd5)
- Where
- 2 sites in Argentina
- Volunteers
- 348 people, healthy volunteers welcome
- Sponsor
- Ministerio de Salud de Ciudad Autónoma de Buenos Aires
COVID19
SARS-CoV-2 (COVID-19) Detection Using the Breath Analizer TeraSystem
The purpose of the study is to verify the sensibility and accuracy of a rapid detection test for SARS-CoV-2 in breath samples analyzed by the breath detector analyzer TeraSystem, comparing with PCR tests.
- Trial name
- NCT04497610
- Testing
- Breath sample
- Where
- Costa Rica
- Volunteers
- healthy volunteers welcome
- Sponsor
- Instituto Costarricense de Investigaciones Clínicas ICIC
All Patients Undergoing COVID 19 Specific Testing
A Study to Determine the Role of Physician Gestalt in Predicting COVID-19 in Patients
THIS IS A PROSPECTIVE OBSERVATIONAL STUDY TO DETERMINE THE ROLE OF PHYSICIAN GESTALT IN CLINICAL PREDICTION OF COVID 19.
- Trial name
- NCT04974177
- Where
- India
- Volunteers
- 876 people, healthy volunteers welcome
- Sponsor
- Jubilee Mission Medical College and Research Institute
Covid19, Functional Capacity
Functional Capacity in Survivors of COVID-19 Related ARDS
Acute respiratory distress syndrome survivors frequently develop impaired physical function, muscle weakness and quality of life.
- Conditions
- Covid19, Functional Capacity, Post-intensive Care Syndrome
- Trial name
- NCT04952844
- Where
- Turkey (Türkiye)
- Volunteers
- 15 people
- Sponsor
- Koç University
COVID-19 Infection
COVID-19 in Baselland: Investigation and Validation of Serological Diagnostic Assays and Epidemiological Study of Sars-CoV-2 Specific Antibody Responses
The study is to investigate the antibody response in the blood and saliva of people with a known COVID-19 infection in the canton of Baselland.
- Trial name
- SEROBL-COVID19 (NCT04483908)
- Testing
- blood draw, fingertip tests for POC assays, saliva collection
- Where
- Switzerland
- Volunteers
- 477 people, healthy volunteers welcome
- Sponsor
- University Hospital, Basel, Switzerland
Covid19, SARS-CoV-2
The Impact of SARS-CoV-2 Rapid Antigen Testing Kit Screening in Bangkok Community
Our current focus is to reduce the spread of COVID through distribution of Rapid Antigen Test Kits (ATKs) to low-income, high-risk communities across Bangkok.
- Conditions
- Covid19, SARS-CoV-2, Community Transmissions, Coronavirus Infections
- Trial name
- NCT05047900
- Testing
- Rapid antigen testing kit
- Where
- 6 sites in Thailand
- Volunteers
- 70,000 people
- Sponsor
- Mahidol University
COVID-19
Surveillance of Individuals Following SARS-CoV-2 Infection
Background: People who have had contact with a person with a known SARS-CoV-2 infection are being told to self-quarantine for 14 days. This is done to avoid potential virus spread.
- Trial name
- NCT04383444
- Where
- United States
- Volunteers
- 18 people
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
COVID-19 Testing, Decision Making
Understanding Communications Included With COVID-19 (Corona Virus Disease of 2019) Home Testing Kits
To test competing sets of information for consumers on how to interpret hypothetical SARS-CoV-2 home test kit results and whether they report plans to take CDC-recommended actions to protect themselves and others given their test…
- Trial name
- NCT04758299
- Testing
- decision science-based design
- Where
- United States
- Volunteers
- 360 people, healthy volunteers welcome
- Sponsor
- Barry Dewitt
Positive COVID-19 by PCR
Predictors of COVID-19 Infection and Disease Progression
Clinical Picture: Symptomatic COVID-19 presents with a recognizable clinical syndrome that is predictable prior to testing. Clinical judgement remains important, particularly when interpreting negative test results; 2.
- Trial name
- Portsaiduni (NCT04484597)
- Testing
- Rt PCR
- Where
- Egypt
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- Port Said University